PubRank

Robert Lowsky

Author PubWeight™ 20.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008 4.04
2 Adoptive immunotherapy with cytokine-induced killer cells for patients with relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011 1.96
3 TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood 2009 1.89
4 Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. Blood 2012 1.31
5 Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction. Semin Immunol 2011 1.21
6 NKT cells, Treg, and their interactions in bone marrow transplantation. Eur J Immunol 2010 1.08
7 Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Blood 2004 1.02
8 High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2006 0.93
9 CD34, CD4, and CD8 cell doses do not influence engraftment, graft-versus-host disease, or survival following myeloablative human leukocyte antigen-identical peripheral blood allografting for hematologic malignancies. Exp Hematol 2005 0.91
10 Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update. Curr Opin Hematol 2009 0.86
11 Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma. Biol Blood Marrow Transplant 2010 0.86
12 Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia. Br J Haematol 2010 0.82
13 Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation. Blood 2011 0.82
14 Identification of gene microarray expression profiles in patients with chronic graft-versus-host disease following allogeneic hematopoietic cell transplantation. Clin Immunol 2013 0.80
15 Total lymphoid irradiation for graft-versus-host disease protection. Curr Opin Oncol 2009 0.77
16 Short tandem repeat analysis to monitor chimerism in macaca fascicularis. Am J Transplant 2004 0.76
17 Rare cells predict GVHD. Blood 2012 0.76
18 A technique of bone marrow collection from vertebral bodies of cynomolgus macaques for transplant studies. J Surg Res 2005 0.76